Search PubMed⌕ Search

Biomedical subjects

M Boussinesq

Publications and source records attributed to M Boussinesq.

71 records · Page 4Linked to original sources
PubMed1993

[Long-term effect of a single dose of ivermectin on skin microfilarial density in an endemic onchocerciasis area of North Cameroon].

The long-term efficacy of a single dose of ivermectin (150 micrograms/kg) on skin microfilarial densities was evaluated by comparing parasite levels, before and after treatment, in 192 patients living in an area endemic for onchocerciasis in North Cameroon. A mass treatment with ivermectin has been undertaken in 1989 in two villages, where pretreatment community microfilarial loads (CMFL) were 5.5 and 25.1 microfilariae per snip. The parasitological examination carried out 32 months later showed that the microfilarial densities in the adults where only 24 and 51% of the initial values, respectively. In a third village, treated once in 1989 but located in an area where annual mass distributions of ivermectin have been undertaken since 1987, the mean microfilarial density 28 months after treatment was only 12% of the initial value. In 1992, the mean microfilarial load in children had decreased significantly in comparison with those of 1989 only in the village where the level of endemicity was initially the lowest. The rate of increase in the number of skin microfilariae after one dose of ivermectin is related with the pretreatment endemicity level. The impact of large-scale ivermectin treatments on the transmission of onchocerciasis enhances the long-term efficacy of this drug on the skin microfilarial densities.

Adult↗
PubMed1993

[Parasitological efficacy of repeated treatments with ivermectin in an onchocerciasis focus in north Cameroon].

321 adults living in an hyperendemic onchocerciasis focus in North-Cameroon who received a first dose of ivermectin (150 micrograms/kg) in 1987 and a total of three, four or five doses from 1987 to 1991 were parasitologically examined in 1992. The prevalence of skin microfilariae (PMf) and the geometric mean microfilarial load (GMMf) were respectively reduced by 33 and 97% from the initial values in the group of subjects who received five treatments. In 1992, the PMf and the GMMf were not significantly different in the groups which received three, four or five doses of ivermectin. It is not necessary to achieve an important drug coverage to maintain a tolerable level of infestation in the community.

Adult↗
PubMed1991

[Control of onchocerciasis with ivermectin: results of a mass campaign in northern Cameroon].

A mass chemotherapy campaign to treat onchocerciasis with ivermectin was carried out in northern Cameroon, in the North Vina valley, a savanna area that is part of the extended Vina-Pendé-Longone focus. More than 20,000 people aged five years and over were treated at least once and more than 30,000 treatments were distributed. One to four treatments were given at intervals of six months or one year. Clinical and parasitological examinations of representative samples of the treated population and full ophthalmological examinations of males aged 15 to 35 years were carried out before each treatment to assess the efficacy of the different protocols of treatment. Secondary effects were recorded daily during the week after administration of ivermectin in the whole population treated. The evolution of arterial blood pressure was monitored over seven days in about 300 adults living in the hyperendemic region. The impact of mass treatment on natural transmission of the disease was evaluated by daily capture and dissection of blackflies during the month before and the two months after treatment. All levels of onchocerciasis endemicity were represented in the study area (maximum community microfilarial load (CMFL), 300 microfilariae per biopsy). Six months and one year after the first treatment, loads were down by more than 90% and more than 60% respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗
PubMedDate not supplied

Efficacy of repeated doses of ivermectin against Mansonella perstans.

Treatment of Mansonella perstans infection, although seldom necessary, is difficult. In a 3 year's trial of normal and high-dose annual and 3-monthly ivermectin treatment against Onchocerca volvulus, the effects on M. perstans were recorded and related to the cumulative dose received. The World Health Organization's African Programme for Onchocerciasis Control may thus reduce the endemicity of M. perstans.

Adult↗
PubMedDate not supplied

Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon.

Studies conducted during the past 10 years to investigate the possible relationship between onchocerciasis and epilepsy have led to contradictory results. In 1991-92 and 2001 we investigated 14 villages in central Cameroon to evaluate the relationship, at the community level, between the prevalence of epilepsy and the endemicity level of onchocerciasis. A case-control study compared the microfilarial loads of 72 epileptic and 72 non-epileptic individuals, matched according to sex, age, and village of residence. The prevalence of epilepsy and the community microfilarial load (CMFL) were closely related (P < 0.02), and the case-control study demonstrated that the microfilarial loads (microfilariae per snip) in the epileptic group (arithmetic mean = 288, median = 216) were significantly higher (P < 10(-4)) than in the control group (arithmetic mean = 141, median = 63). The results strongly support the existence of a link between onchocerciasis and epilepsy. The fact that such a relationship has not been found recently in some other West and Central African areas is probably due to the lowered endemicity of onchocerciasis following vector- and ivermectin-related control measures applied over the past 5-25 years. The socio-economic and demographic impact of onchocerciasis-related epilepsy should be evaluated, and taken into account as part of all onchocerciasis control programmes.

Adolescent↗
PubMedDate not supplied

Ivermectin-based control of onchocerciasis in northern Cameroon: individual factors influencing participation in community treatment.

A study aimed at determining individual factors associated with participation in community treatment with ivermectin was conducted in a village hyperendemic for onchocerciasis in northern Cameroon. The respective influences of sex, age, place of residence, distance between the compound and the dosing point, compound size, and participation in treatment by authoritative individuals in the compound was evaluated using univariate and multivariate analysis. Participation in treatment was closely associated with the attitude of the compound heads. Participation of compound heads in treatment increased as the household size increased, and as the distance to the distribution point diminished. This may be explained by the fact that getting information on health programmes is easier in large households whose members are involved in various social activities, and in compounds located near the village centre. Staff involved in health education should take this issue into account, and try to ensure circulation of information particularly to those living in small or remote compounds.

Adolescent↗
PubMedDate not supplied

Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments.

The impact of repeated ivermectin treatments on the transmission of Onchocerca volvulus was evaluated in the Vina valley, northern Cameroon, by comparing the prevalence and intensity of infection observed in untreated 5-7 years old children living in the treated communities before and after 7-8 successive annual rounds of ivermectin treatment of the general population of those communities. The villages studied were Ngoumi and Babidan, where the initial community microfilarial loads (CMFL) were 83.7 and 216.4 microfilariae per skin snip, respectively. In 1995, after 8 annual treatments, the prevalence and intensity in Ngoumi had decreased by more than 90%, compared with the pretreatment values, and the prevalence continued to decrease between 1992 and 1995. In Babidan, after 7 annual treatments, the prevalence and intensity had also decreased significantly, but less than in Ngoumi. The study demonstrated that repeated treatments brought about a notable reduction in the transmission of O. volvulus in the Vina valley, despite unfavourable factors such as mean drug coverages below 60% and the good vectorial competence of Simulium damnosum s.s. and S. sirbanum.

Adult↗
PubMedDate not supplied

Impact of repeated large scale ivermectin treatments on the transmission of Loa loa.

We have studied the impact of large-scale treatment with ivermectin on the transmission of loiasis in a forest village in south Cameroon where loiasis was highly endemic, with a prevalence of 30%. After one year of parasitological and entomological surveillance without treatment, all consenting residents aged > 5 years received ivermectin 200 micrograms/kg every 3 months. For ethical reasons, treatment was interrupted after 2 years, but parasitological and entomological surveillance continued for 18 months after the end of treatment. The prevalence of loiasis was reduced to < 10% and the mean microfilaraemia decreased by 90% in 2 years. The prevalence and average intensity of infection remained stable during the 18 months after treatment ended. Two vector species were identified, Chrysops dimidiata (representing about 90% of the fly population) and C. silacea. The infection rate (all stages) in Chrysops decreased by 75% and the infective rate (percentage of Chrysops harbouring third-stage larvae of Loa loa in the head) decreased by 85% in C. dimidiata and became zero in C. silacea. After the end of treatment, the infection and infective rates increased gradually. Large-scale treatment seemed an efficient method for the control of L. loa transmission provided high drug coverage was achieved. Nevertheless, because of the high risk of adverse effects when using the current microfilaricidal drugs, such a strategy remains unacceptable.

Animals↗
PubMedDate not supplied

Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy.

A review and a meta-analysis of the available epidemiological literature for evidence of an association between onchocerciasis infection and epilepsy were carried out. We used EMBASE (1974-2002), MEDLINE (1966-2002), and PASCAL (1987-2002) databases and relevant journals and bibliographies. We limited our analysis to the epidemiological studies, where the status regarding onchocerciasis infection and epilepsy was available for each subject. Nine African studies were included. The common relative risk estimated by the random-effects model was 1.21 (95% CI 0.99-1.47; p = 0.06). The meta-analysis did not show any difference according to the onchocerciasis endemicity level and the African areas. Our results do not allow to conclude for an association between Onchocerca volvulus infection and epilepsy. However, the results are nearly significant. Further research is needed in this neglected subject, in particular for the better understanding of the neurological pathogenicity in onchocerciasis.

Brain Diseases↗
PubMedDate not supplied

[Geographic determinants of onchocerciasis transmission in a forest-savannah transition zone: an example of 2 villages of the Mbam focus (central region, Cameroon)].

Mbam, a focus of onchocerciasis outbreaks, is located in the forest/savannah transition zone of Cameroon. Transmission of the disease in this area is similar to that sometimes observed in West Africa. Geographical factors affecting transmission must be identified to determine the areas for priority action. The locations of breeding sites for black flies (the vector of the disease) and factors favorable to their dispersion, the social behavior of these population and the way that she occupy space, must be investigated to identify areas in which the flies and man are in close contact. This geographical study shows that the closest contact between men and black flies occurs in cocoa plantations, due to the proximity of the breeding sites. The areas of closet contact for women and children are unknown, but their identification is important because women and children may be bitten by the flies during their daily activities.

Adolescent↗
PubMedDate not supplied

[The use of ivermectin in the control of onchocerciasis].

Onchocerciasis is an infection with the nematode Onchocerca volvulus. The main clinical symptoms are caused by the microfilariae. They include ocular lesions leading to blindness. Onchocerciasis is widely distributed in Africa from the Sahara to the southern tip, and is also found in some areas of South and Central America. Ivermectin was shown to be an effective treatment in the early 1980's, and is safe and better tolerated than diethylcarbamazine. We report the results of ivermectin treatment of onchocerciasis, and various features of the control obtained by large-scale ivermectin treatment programs. In large-scale programs, ivermectin (150 micrograms/kg) is administered once a year. This dose paralyses the microfilariae, such that they are carried away by the lymph to the lymph nodes where they are destroyed. This dose thereby reduces the load of microfilaria by 90%. The effects of a dose of ivermectin last about two or three years, and the lesions in the anterior segment of the eye can be cured or substantially reduced. Regular treatment prevents severe lesions of the posterior segment of the eye. The effects of repeated treatment on lesions of the retina are currently under investigation. Frequent doses of ivermectin prevent the development of embryo parasites in the females, and reduces the number of adults by attrition. Large-scale treatment programs reduce the transmission of the parasite by its vectors. There are several problems impeding large-scale treatment programs. Choosing patients for priority treatment requires expensive and sometimes aggressive methods of diagnosis. Thus new techniques for the identification of communities in which onchocerciasis is a serious public health problem are required. The choice of strategies for distribution, to optimize the cost, benefit ratio and feasibility, remain controversial. Wide distribution by mobile teams is effective, but expensive. Active distribution by trained community distributors is a cheaper potential alternative. Clinic-based or passive distribution requires the population to present to be able to obtain ivermectin. Thus, although cheap, this approach is generally poorly effective. A further complication is the clearly defined criteria on which these methods should be evaluated.

Africa↗